• New Orleans creates economic value out of environmental vulnerability

    Following the devastation of Hurricane Katrina in 2005, New Orleans and the state of Louisiana have become so adept at dealing with disaster reconstruction, that their new-found skills are now seen as an economic asset to be shared, for profit, with other states and localities. The area’s new environmental awareness is also a source of economic growth, as analysts now consider “emerging environmental” as one of six key industries in the city and state to focus on development, along with coastal restoration and water management, disaster mitigation and management, hazardous waste disposal, advanced bio fuels and waste water treatment.

  • Growing cyberthreats lead to growing interest in cybersecurity insurance

    The increasing sophistication and scope of cyberattacks on businesses – and the increasing damage such attacks are causing – have led to growing interest in cybersecurity insurance. The industry is urging the government to treat cyberattacks as acts of terrorism which should be covered under the Terrorism Risk Insurance Act(TRIA), while also looking into how the Stafford Actcould help companies after a cyberterror attack. At the same time, more private insurers are offering limited cyber-coverage, but many say they would discontinue selling cyber policies if TRIA is not renewed. As the term “cyber-coverage” continues to be defined by large insurers, the insurance product lines continue to change.

  • Who is to blame when iCloud is "hacked" – you or Apple?

    By Grant Bollmer

    A hacker’s release of personal photos of actress Jennifer Lawrence and other female celebrities on the Internet on the weekend has again drawn our attention to the security of our personal information online. Apple may wish to absolve itself of responsibility when individuals lose control of their personal data, yet understanding the control of data as a personal matter disregards how iCloud and similar services actually operate. If Apple and other cloud-based services want our trust, then they have to acknowledge the role their products play in perpetuating anxieties of data-out-of-control.

  • Atlanta’s rapid transit deploys AI video analytics to bolster public safety

    The Metropolitan Atlanta Rapid Transit Authority (MARTA) is deploying Behavioral Recognition Systems’ AISight, an artificial intelligence-based analytics solution that teaches itself to recognize and alert on unexpected patterns within massive volumes of data.

    • view counter

  • NIH launching human safety study of Ebola vaccine candidate

    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), will this week begin initial human testing of an investigational vaccine to prevent Ebola virus disease. The early-stage trial will begin initial human testing of a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) and will evaluate the experimental vaccine’s safety and ability to generate an immune system response in healthy adults. The study is the first of several Phase 1 clinical trials that will examine the investigational NIAID/GSK Ebola vaccine and an experimental Ebola vaccine developed by the Public Health Agency of Canada and licensed to NewLink Genetics Corp.

  • Deterring cyberattacks requires building a public-private partnership

    Cyberattacks loom as an increasingly dire threat to privacy, national security, and the global economy, and the best way to blunt their impact may be a public-private partnership between government and business, researchers say. The time to act is now, however, rather than in the wake of a crisis, says an expert in law and technology. The expert says that an information-sharing framework is necessary to combat cybersecurity threats.

    • view counter

  • Epidemic ethics: four lessons from the current Ebola outbreak

    By Ian Kerridge

    The extent of the current Ebola virus outbreak in West Africa has belatedly focused the attention of non-governmental organizations, local and Western governments, and international media. What we haven’t caught up with though, is the extent to which these outbreaks and their devastating effects are predictable and preventable. The spread of Ebola virus occurs because health infrastructure in the region is fragmented, under-resourced, or non-existent. And the therapeutic response to the illness is constrained by failure of markets to drive drug and vaccine development that would help the world’s poorest people.

  • Maryland creates fund to support cybersecurity startups

    The Maryland Technology Development Corporation, (TEDCO) an independent public organization founded by the Maryland General Assemblyand funded by the state, has created a $1 million fund to invest in startups developing new cybersecurity technologies.

  • Neumedicines receives $14m for acute radiation exposure countermeasures

    Neumedicines receives $14 million from BARDA to support advanced development of HemaMax, including advanced GMP manufacturing activities and a Phase 2 clinical safety study in 200 healthy human volunteers. The company says its efficacy studies have shown that a single, low-dose, subcutaneous injection of HemaMax at twenty-four hours after exposure to lethal radiation increases survival by an average of more than 2-fold without any supportive care or antibiotics.

  • New tool reveals which online personal data is being used by advertisers

    The Web can be an opaque black box: it leverages our personal information without our knowledge or control. When, for instance, a user sees an ad about depression online, she may not realize that she is seeing it because she recently sent an e-mail about being sad. A new tool reveals which data in a Web account, such as e-mails, searches, or viewed products, are being used to target which outputs, such as ads, recommended products, or prices.

  • Isolation: More countries sever trade, transportation links with Ebola-affected states

    The World Health Organization (WHO) has called on governments not to impose sweeping bans on trade and travel on Ebola-affected countries. The organization’s urgent call followed the announcement by Kenya that it was joining a growing list of countries severing all trade and transportation links to the three west African countries most affected by Ebola – Guinea, Liberia, and Sierra Leone. Independently of government actions, many airlines have already stopped flying to and from the three countries. The disease has already killed at least 1,145 people in these three countries and in Nigeria.

  • Three infected Liberian health workers receive rare Ebola serum

    Three Liberian health care workers who have been infected with the Ebola virus while treating patients, have on Friday received a scarce experimental serum – Zmapp — at a hospital outside the national capital, Monrovia, the Liberian capital. This is the same serum given to two American workers, Dr. Kent Brantly and Nancy Writebol, who contracted Ebola while working at ELWA Hospital in Monrovia. Brantly and Writebol were evacuated to Emory University Hospital in Atlanta, where they have been showing promising signs of recovering from the disease. Mapp Biopharmaceutical of San Diego, which provided the drug, said the “available supply of ZMapp has been exhausted.”

  • Energy companies slow to buy cyberdamage insurance

    The U.S. oil industry will spend $1.87 billion on cybersecurity defense systems by 2018, but less than 20 percent of U.S. companies overall are covered for cyberdamages. “Imagine what could happen if a large refinery or petrochemical facility’s safety monitoring systems were hijacked near an urban area, or a subsea control module was no longer able to be controlled by the people who should be controlling it,” says one expert. “As we’ve all seen from Deepwater Horizon [the 2010 BP Gulf oil spill] those risks and damages can be astronomical. It requires an immediate response.”

  • The CDC contracts Emergent BioSolutions for $18.9 million smallpox treatment

    The CDC has contracted Emergent BioSolutions for the supply of Vaccinia Immune Globulin Intravenous (VIGIV) into the U.S. Strategic National Stockpile (SNS). VIGIV is a therapeutic licensed by the U.S. Food and Drug Administration (FDA) for the treatment of complications due to smallpox vaccination. The contract options are valued at $18.9 million over three years.

  • Ebola vaccine to be tested on humans

    Efforts to test an Ebola vaccine on humans have reached a milestone when BioProtection Systems, through its parent company, NewLink Genetics Corporation, confirmed that it is prepared to launch the first human safety trial of a vaccine, which the company licensed after it was developed by scientists at the Public Health Agency of Canada. Thevaccine replaces the genes from vesicular stomatitis virus (VSV), a pathogen found in livestock, with a gene from the Ebola virus. The Ebola gene then develops a harmless protein that sits on the virus’s outer coat.